<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 24-year-old male patient was admitted to the coronary intensive care unit with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> with rapid ventricular response </plain></SENT>
<SENT sid="1" pm="."><plain>He was given <z:chebi fb="0" ids="2663">amiodarone</z:chebi> (Cordarone 150 mg i.v., Sanofi-Aventis) intravenous loading dose of 300 mg in 100 mL <z:chebi fb="10" ids="4167">dextrose</z:chebi> 5% in water (D5W) over 1 hour, followed by a maintenance dose of 900 mg in 500 mL D5W for infusion up to 24 hours </plain></SENT>
<SENT sid="2" pm="."><plain>At the emergency department, the patient was conscious and cooperative; his pretreatment arterial blood pressure was 120/80 mm Hg, and the arrhythmic <z:hpo ids='HP_0001649'>tachycardia</z:hpo> was 145 per minute </plain></SENT>
<SENT sid="3" pm="."><plain>After intravenous <z:chebi fb="0" ids="2663">amiodarone</z:chebi> loading and half an hour into maintenance infusion, extreme perspiration, <z:hpo ids='HP_0002615'>hypotension</z:hpo> (blood pressure immeasurable), and mild <z:hpo ids='HP_0000961'>cyanosis</z:hpo> developed </plain></SENT>
<SENT sid="4" pm="."><plain>The patient was conscious; his auscultation and pulse were <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>He was given physiologic serum and <z:chebi fb="40" ids="18243">dopamine</z:chebi> support </plain></SENT>
<SENT sid="6" pm="."><plain>Approximately an hour later, the blood pressure was measurable </plain></SENT>
<SENT sid="7" pm="."><plain>Infusion was terminated because of suspicion of an allergic reaction to <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> or <z:chebi fb="0" ids="2663">amiodarone</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>The allergic reaction observed was attributed to <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> and <z:chebi fb="0" ids="2663">amiodarone</z:chebi>; infusion was resumed when the clinical situation worsened during the maintenance infusion </plain></SENT>
<SENT sid="9" pm="."><plain>Once again, the patient was given physiologic serum (2000 mL), <z:chebi fb="40" ids="18243">dopamine</z:chebi> (20 mg/kg per minute), and, additionally, 250 mg of methyprednisolone <z:chebi fb="199" ids="26708">sodium</z:chebi> succinate intravenous, whereby the clinical condition improved within 20 minutes </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0100845'>Anaphylactic shock</z:hpo> cases due to <z:chebi fb="0" ids="2663">amiodarone</z:chebi> are rare; it is important to take a history of drug-mediated <z:mp ids='MP_0002531'>anaphylaxis</z:mp> before prescribing <z:chebi fb="0" ids="2663">amiodarone</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>An addition to a review of the literature regarding treatment of <z:chebi fb="0" ids="2663">amiodarone</z:chebi>-related <z:hpo ids='HP_0100845'>anaphylactic shock</z:hpo> cases had not been reported before </plain></SENT>
</text></document>